News and Announcements

Sales jump at GSK on strong demand for specialty drugs

By Abigail Townsend

Date: Wednesday 29 Apr 2026

(Sharecast News) - GSK posted above-forecast first-quarter profits on Wednesday, boosted by robust demand for its specialist HIV and oncology drugs.
The blue chip pharma saw sales rise 2%, or by 5% on a constant currency basis, to £7.6bn, while core earnings per share came in at 46.5p per share, up...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page